International Clinical Trial: A study on Using ayurvedic medicines Kumari Asava and Amalaki Alongside Regular Care for Severe Tuberculosis

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117425) titled 'A study on Using ayurvedic medicines Kumari Asava and Amalaki Alongside Regular Care for Severe Tuberculosis' on Sept. 10.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Case Record Numbers Blinding and masking:Open Label

Primary Sponsor: Maharashtra University of Health Sciences Nashik

Condition: Health Condition 1: A150- Tuberculosis of lung

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 15-10-2026

Target Sample S...